TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| How Concerned Should Onyx Investors Be? EP Vantage submits:Another weak quarter for kidney and liver cancer treatment Nexavar prompted a 5% drop in Onyx Pharmaceuticals’ (ONXX) shares Thursday and questions about what exactly is driving the disappointing figures. The sales were reported by Onyx’s marketing partner Bayer and when the US biotech reports first quarter figures next week, no doubt the subject will take center stage; some financial analysts have already moved to significantly trim sales forecasts. Just how concerned followers of the US biotech should be remains to be seen, but with competition from newer agents biting in its biggest market, kidney cancer, Onyx needs to demonstrate that demand for Nexavar will pick up.Complete Story » seekingalpha.com |
Intellipharmaceutics CEO Molded by Biovail Bio Tuesday submits: Fifteen years ago, Dr. Isa Odidi performed magic as CSO of Biovail (NYSE:BVF), developing several blockbuster generics, including hard-to-manufacture copies of Bayer’s (BAYRY.PK) Adalat CC, Pfizer’s (PFE) Procardia XL and Novartis’ (NVS) Voltaren XR. “We have the same style here at Intellipharmaceutics (NASDAQ:IPCI) as we had at Biovail,” Dr. Odidi says in an exclusive interview with BioTuesday.ca. “It’s the library system approach. If you want a book at the library, you take it off the shelf. Likewise, we have a lot of compounds at various stages of development and as we file one, we bring another one forward.”Complete Story » seekingalpha.com |
Avastin's Breast Cancer Indication Falters, FDA Panel Says An FDA advisory panel called on the agency to revoke its approval of Roche's Avastin as a breast-cancer treatment after studies failed to show benefit. online.wsj.com |
Small Cap Biotech Stocks: 7 Picks, 1 Big Concern Peter Navarro submits: Why I Like Biotech Stocks Biotech stocks are great to trade in a sideways market because they move mostly on science, not the economy.Biotech stocks have high risk but high reward – my 15-bagger of the year was Prolor Biotech (PBTH.OB), which went from 40 cents to 7 bucks and now trades on the Amex. How to Find Biotech Stocks Complete Story » seekingalpha.com |
Test-Tube Baby Pioneer Wins Nobel British researcher Robert G. Edwards developed in-vitro fertilization and gave thousands of infertile couples the chance to have children. online.wsj.com |